In addition, SOX2 overexpression subsequently increased the tumor incidence and the frequency of tumorigenic cells among both control and METTL3 knockdown SW620 cells (Fig. 4d and Additional file 7: Figures S4c-d). The gene discussed is METTL3; the disease is neoplasm.